SPX3,678.43+92.81 2.59%
DIA294.79+7.49 2.61%
IXIC10,815.44+239.82 2.27%

Truist Securities Adjusts Gilead Sciences Price Target to $76 From $71, Maintains Hold Rating

Truist Securities Adjusts Gilead Sciences Price Target to $76 From $71, Maintains Hold Rating

MT Newswires · 09/14/2022 06:25

Please log in to view news